Acta Neuropharmacologica ›› 2012, Vol. 2 ›› Issue (4): 32-39.
Previous Articles Next Articles
WU Hai-xia,WU Zhi-gang,LIU Hong-bin,SHEN Li-xia
Online:
2012-08-26
Published:
2014-06-27
Contact:
沈丽霞,女,博士,教授;研究方向:神经药理学;Tel:+86-0313-4029423,E-mail:shenlixiacn@163.com
About author:
武海霞,女,硕士,讲师;研究方向:神经药理学;Tel:+86-0313-4029305,E-mail:wuhaixia_zjk@126.com
Supported by:
河北省自然科学基金资助项目(No.H2012405016),河北省教育厅资助项目(No.Z2013069),河北北方学院创新人才培育基金(CXRC1325),2013年度河北北方学院校级重大项目(ZD201310)
CLC Number:
WU Hai-xia,WU Zhi-gang,LIU Hong-bin,SHEN Li-xia. Signal Transduction of Toll-like Receptors and the Central Nervous System Disease[J]. Acta Neuropharmacologica, 2012, 2(4): 32-39.
[1] Christiane Nusslein-Volhard, Eric Wieschaus. Mutations affecting segment number and polarity in Drosophila[J].Nature, 1980, 287(5785):795-801.[2] Carl Hashimoto, Kathy L Hudson, Kathryn V Anderson. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein[J].Cell, 1988, 52(2): 269-279.[3] Nicholas J Gay, Fionna J Keith. Drosophila Toll and IL-1 receptor[J].Nature, 1991, 351(6325): 355-356.[4] Nobuo Nomura, Nobuyuki Miyajima, Takashi Sazuka, et al. Prediction of the coding sequences of unidentified human genes.I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1[J].DNA Reserch, 1995, 1(1):27-35.[5] Bruno Lemaitre, Emmanuelle Nicolas, Lydia Michaut, et al. The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults[J].Cell, 1996, 86(6):973-983.[6] Ruslan Medzhitov, Paula Preston-Hurlburt, Charles A Janeway. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J].Nature, 1997, 388(6640): 394-397.[7] Xin Du, Alexander Poltorak, Yongie Wei, et al. Three novel mammalian toll-like receptors: gene structure, expression, and evolution[J].European Cytokine Network, 2000, 11(3): 362-371.[8] Amy Rasley, Juan Anguita, Ian Marriott. Borrelia burgdorferi induces inflammatory mediator production by murine microglia[J].J Neuroimmunol, 2002, 130(1):22-31. [9] Shizuo Akira, Kiyoshi Takeda. Toll-like recepror signaling[J].Nst Rev Immunol, 2004, 4(7):499-511.[10] Maria Fischer, Marc Ehlers. Toll-like receptors in autoimmunity[J].Ann N Y Acad Sci, 2008, 1143(12):21-34.[11] Taro Kawai, Shizuo Akira. The role of pattern recognition receptors in innate immunity: update on Toll-like receptors[J].Nature Immunology, 2010, 11(5): 373-384.[12] Thomas R.Hawn, Delia Scholes, Shuying S Li, et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women[J].PLoS One, 2009, 4(6): e5990.[13] Marta Muzio, Daniela Bosisio, Nadia Polentarutti, et al. Differential expression and regulation of Toll-like receptors(TLR) in human leukocytes:Selective expression of TLR3 in dendritic cells[J].J Immunol, 2000, 164(11): 5998-6004.[14] Cinthia Farina, Markus Krumbholz, Thomas Giese, et al. Preferential expression and function of Toll-like receptors in human astrocytes[J].J Neuroimmunol, 2005, 159 (12):12-19.[15] Emmanuel L Gautier, Tal Shay, Jennifer Miller, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages[J].Nat Immunol, 2012, 13(11): 1118-1128.[16] KiyoshiTakeda, Shizuo Akira. Toll-like receptors in innate immunity[J].Int Immunol, 2005, 17(1): 1-14.[17] Fabia Brentano, Diego Kyburz, Olivier Schorr, et al. The role of Toll-like receptor signaling in the pathogenesis of arthritis[J].Cell Immunol, 2005, 233(2):90-96.[18] Luke A O’Neill, Andrew G Bowie. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling [J].Nat Rev Immunol, 2007, 7(5): 353-364.[19] Chao Zheng, Qian Yin, Hao Wu. Structural studies of NF-κB signaling[J].Cell Res, 2011, 21(1): 183-195.[20] Oliver A Harari, James K Liao. NF-κB and innate immunity in ischemic stroke[J].Ann N Y Acad Sci, 2010, 1207(10): 32-40.[21] Jesus M Pradillo, David Fernandez-Lopez, Isaac Garcia-Yebenes, et al. Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning[J].J Neurochem, 2009, 109(1): 287-294.[22] Bi Xiao-ying, Bin Yan, Fang Shao-kuan, et al. Quetiapine regulates neurogenesis in ischemic mice by inhibiting NF-kappaB p65/p50 expression[J].Neurol Res, 2009, 31(2):159-166.[23] Ting Wang, Jun Gu, Peng-Fei Wu, et al. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation[J].Free Radic Biol Med, 2009, 47(3): 229-240.[24] Emma M Creagh, Luke A J O’Neill. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity[J].Trends Immunol, 2006, 27(8): 352-357.[25] Peter Ulrichts, Jan Tavernier. MAPPIT analysis of early Toll like receptor signalling events [J].Immunol Letters, 2008, 116(2):141-148.[26] Paul Cormican, Andrew T Lloyd, Tim Downing, et al. The avian Toll-Like receptor pathway- subtle differences amidst general conformity[J].Dev Comp Immunol, 2009, 33(9): 967-973.[27] Arezoo Campbell. Inflammation, neurodegenerative diseases, and environmental exposures[J].Ann N Y Acad Sci, 2004, 1035(12): 117-132.[28] Eitan Okun, Kathleen J Grffioen, Justin D Lathia, et al. Toll-like receptors in neurodegeneration[J].Brain Res Rev, 2009, 59(2): 278-292.[29] An Hua-zhang, Qian Cheng, Cao Xue-tao. Regulation of Toll-like receptor signaling in the innate immunity[J].Sci China Life Sci, 2010, 53(1): 34-43.[30] Sumana Chakravarty, Miles Herkenham. Toll-like receptor 4 on nonhematopoietic cells sustains CNS inflammation during endotoxemia, independent of systemic cytokines[J].J Neuroscience, 2005, 25(7): 1788-1796 .[31] Rajagopal N Aravalli, Phillip K Peterson, James R Lokensqard. Toll-like receptors indefense and damage of the central nervous system[J],J Neuroimmune Pharmacol, 2007, 2(4):297-312.[32] Asya Rolls, Ravid Shechter, Anat London, et al. Toll-like receptors modulate adult hippocampal neurogenesis[J].Nat Cell Biol, 2007, 9(9): 1081-1088.[33] Yin Gao, Fang Xiu-bin, Tong Yue, et al.TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice[J]. Biomed & Pharmacother, 2009, 63(6): 442-450.[34] Lalancette-Hebert M, Phaneuf D, Soucy G, et al. Live imaging of Toll-like receptor 2 response in cerebral ischemia reveals a role of olfactory bulb microglia as modulators of inflammation[J].Brain, 2009, 199(1):75-82.[35] Min Li, Zang Xiang-jian, Cui Li-li, et al. The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of nrf2 and hemeoxygenase-1 expression[J].Biol Pharm Bull, 2011, 34(5): 595-601.[36] Qiao Hui-min, Zhang Xiang-jian, Zhu Chun-hua, et al. Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia[J].Brain Res, 2012, 1448(4): 71-81.[37] 王敏, 王永明, 李海东, 等. 白蛋白治疗对小鼠脑缺血早期脑组织Toll样受体4和骨髓分化因子88 mRNA表达的影响[J].中华老年心血管病杂志, 2011, 13(2): 164-167.[38] Qiu Jian-hua, Xu Jian, ZhenYi g, et al. High-mobility group box 1 promotes metallo proteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia[J]. Stroke, 2010, 41(9): 2077-2082.[39] 马跃文, 何曼, 强琳. 跑台训练对大鼠脑缺血再灌注后脑组织toll样受体2、toll样受体4信号转导通路活性的影响[J].中国康复医学杂志, 2013, 28(4): 305-310.[40] Yang Qing-wu, Xiang Jing, Zhou Yu, et al. Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebralischemia[J]. Front Biosci(Schol Ed), 2010, 2(6): 1081-1091.[41] Sun Peng, Zhang Qing, Han Ji-yuan, et al.TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfusion in vitro[J].Sci China Life Sci, 2010, 53(2): 223-228.[42] Hua Fang, Ma Jing, Ha Tuan-zhu, et al. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice[J].Brain Research, 2009, 1262(3): 100-108.[43] 谢芬, 方建业, 潘经锐, 等. 脑缺血再灌注早期梗死灶边缘区TLR9信号通路的活化[J].中国神经精神疾病杂志, 2011, 37(10): 596-599.[44] Chao Wang, Yang Zhi-yong, Lu Hua, et al. Mechanisms of Toll-like receptor 4 singaling pathway in early brain damage following sub-arachnoid emorrhage[J].J Internat Neurol Neuro, 2012, 39(1): 25-28.[45] Khalid A Hanafy. The role of microglia and the TLR4 pathway in neuronal apop- tosis and vasospasm after subarachnoid hemorrhage[J].J Neuroinflammation, 2013, 10(7):83[46] 吴颐, 高觉民, 史继新. 罗格列酮对大鼠蛛网膜下腔出血后脑血管痉挛的保护作用[J].中国脑血管病杂志, 2013, 10(11): 588-593.[47] 易帅, 霍晓川, 甄为, 等. Toll样受体4拮抗剂防治兔蛛网膜下腔出血后迟发型血管痉挛[J].解放军医学院学报, 2014, 35(2): 157-160[48] 吴瑞, 刘玲, 彭正午, 等. IgG刺激诱发的小胶质细胞Toll样受体4表达及细胞因子分泌[J].细胞与分子免疫学杂志, 2009, 25(3): 201-207.[49] Kazuyuki Takata, Yoshihisa Kitamura, Takashi Taniguchi. Pathological changes induced by Amyloid-β in Alzheimer’s disease[J].Yakuqaku Zasshi, 2011, 131(1):3. [50] Izumi Maezawa, Pavel I Zimin, Heike Wulff, et al. Amyloid-β protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity[J].Bio Chem, 2011, 286(5): 3693-3706.[51] Zeng Ke-wu, Fu Hong, Liu Geng-xin, et al. Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neuron by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways[J].Int Immunopharmacol, 2010, 10(6): 668-678.[52] 张海燕, 刘忠锦, 陈志伟. 赤芍总苷对D-半乳糖诱导衰老大鼠脑组织TOLL受体和IL-33的实验研究[J].中国中西医结合杂志, 2013, 33(6): 830-833.[53] 张国霞, 周爱玲, 张贵萍, 等. 大鼠海马神经元TLR4介导的MyD88依赖途径在神经炎症中的作用[J].中国应用生理学杂志, 2013, 29(1): 42-46.[54] 黄丰, 邓华明, 朱苗苗, 等. 阿魏酸对脂多糖诱导的小鼠小胶质细胞炎性反应的抑制作用[J].动物学研究, 2011, 32(3): 311-316.[55] 赵保胜, 马群, 刘永刚, 等. 人参皂苷Rg1对神经细胞株NG18-15炎症因子及Toll样受体3、4表达的影响[C].2010年全国中药学术研讨会论文集, 2010:24-29.[56] He Yue, Zhou Ai-ling, Jiang Wei. Toll-like receptor 4-mediated signaling participates in apoptosis of hippocampal neurons[J].Neural Regen Res, 2013, 8(29): 2744-2753.[57] Annamaria Vezzani, Tamas Bartfai, Marco Bianchi, et al. Therapeutic potential of new antiinflammatory drugs[J].Epilepsia, 2011, 52(8): 67-69.[58] Andrey Mazarati, Mattia Maroso, Valentina Lori, et al. High-mobility group box-1 impairs memory in mice through both toll -like receptor 4 and Receptor for Advanced Glycation End Products[J].Exp Neurol, 2011, 232(2): 143-148.[59] 刘国军, 黄瑞雅, 黄建敏, 等. 吡咯二硫代氨基甲酸乙酯对戊四氮致痫大鼠海马组织TLR-4与NF-κB表达的影响[J].中国现代医学杂志, 2013, 23(3): 6-10.[60] Alon Friedman, Ray Dingledine. Molecular cascades that mediate the influence of inflammationon epilepsy[J].Epilepsia, 2011, 52(3): 33-39.[61] 刘希金, 殷亚萍, 杨志勇, 等. TLR4蛋白在颞叶癫痫大鼠及患者脑组织中表达的改变及意义[J].中国神经免疫学和神经病学杂志, 2013, 20(3): 163-165.[62] 向秋莲, 张慈柳, 彭镜, 等.TLR4、MRP8在内侧颞叶癫痫幼大鼠海马中表达的动态变化[J].中风与神经疾病杂志, 2012, 29(7): 580-584.[63] Madison M Buchanan, Mark Hutchinson, Linda R Watkins, et al. Toll-like receptor 4 in CNS pathologies[J].J Neurochem, 2010, 114(1):13-27.[64] 刘强, 赵春梅, 惠晶, 等.单疱病毒性脑炎小鼠中TLR4和IFN-β表达的研究[J].中国免疫学杂志, 2011, 27(9):791-795.[65] 祁玲, 刘强. HMGB1在小鼠单疱脑炎中的作用探究[J].现代免疫学, 2013, 14 (3): 55-59.[66] Bettina Gerstner, Tara M Desilva, Kerstin Genz, et al. Hyperoxia causes maturation-dependent cell death in the developing white matter[J].J Neurosci, 2008, 28(5):1236-1245.[67] Richard L Auten, Jonathan M Davis. Oxygen toxicity and reactive oxygen species:the devil is in the details[J].Pediatr Res, 2009, 66(2):121-127.[68] 陈坤, 蒋朴, 徐颖, 等. Toll样受体4在新生小鼠常压高氧脑损伤中的作用[J].免疫学杂志, 2012, 28(2): 98-103. |
[1] | SUN Yi,TAN Bo,SU Rui-bin. Biased Ligand——Novel Paradigm for Opioid Analgesics [J]. Acta Neuropharmacologica, 2018, 8(2): 1-7. |
[2] | WANG Bao-lei,WANG Jia,GUO Chun-yan. Study on Antithrombotic Mechanism Based on Platelet Pathway [J]. Acta Neuropharmacologica, 2017, 7(5): 34-38. |
[3] | ZHANG Jing, ZOU Yu-an, DONG Xiao-hua, MA Fei, WANG Huan-huan. Experimental Study on Protective Effect of Ischemic Preconditioning on Ischemia-Reperfusion Injury [J]. Acta Neuropharmacologica, 2015, 5(6): 1-5. |
[4] | WANG Qi,DUAN Leng-xin. Progress on the Involvement of GRP78 and ATF4 – CHOP – Puma Signaling Pathway in Endoplasmic Reticulum Stress and Parkinson's Disease [J]. Acta Neuropharmacologica, 2013, 3(3): 19-26. |
[5] | YUAN Heng-jie,LOU Jian-shi. Research Progress in the Mechanisms of Cerebral Ischemia Hypoxia Preconditioning Antagonizing Cerebral Ischemia and Hypoxia Injury [J]. Acta Neuropharmacologica, 2011, 1(4): 42-47. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||